Bio Path Holdings Inc (BPTH)

NASDAQ
6.48
-0.01(-0.15%)
After Hours
6.30
-0.18(-2.78%)
- Real-time Data
  • Volume:
    60,940
  • Bid/Ask:
    6.24/6.53
  • Day's Range:
    6.31 - 6.48

BPTH Overview

Prev. Close
6.49
Day's Range
6.31-6.48
Revenue
-
Open
6.38
52 wk Range
3.12-24.17
EPS
-2.38
Volume
60,940
Market Cap
45.1M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
568,996
P/E Ratio
-
Beta
1.89
1-Year Change
24.86%
Shares Outstanding
6,960,164
Next Earnings Date
Aug 19, 2021
What is your sentiment on Bio Path Holdings Inc?
or
Market is currently closed. Voting is open during market hours.

Bio Path Holdings Inc News

Bio Path Holdings Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuySell
Technical IndicatorsBuyBuySellStrong BuyBuy
SummaryStrong BuyStrong BuyNeutralStrong BuyNeutral

Bio Path Holdings Inc Company Profile

Bio Path Holdings Inc Company Profile

Employees
10

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. The company is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and prexigebersen-A for various solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.

Read More
  • why is this the only one green now
    0
    • Check OCGN
      0
  • no thoughts on this
    0
    • I will hold I think After the FDA approvel it will 🚀🚀🚀
      1
  • just bought some on this dip....🚀🚀🚀 let's go again..
    0
    • where do we see this going. Got distracted and missed my exit, down 57%
      0
      • There might be something by the end of the month
        0
    • Even if no short squeeze to $700-800 due to its small 4 million shares float. Fundamentally, this stock will gradually move to $30-35 by 2022 after getting awarded the patent for their DNAbilize. This company really have the potential as it has hit $700-800 before. Then it has 2 stock splits 1:10 and then 1:20, so now is consider early bird accumulation phase. We will see it go above $30 by end of the week.
      1
      • Saxo bank reports year average price target 10$. Company has 9 employees. Market cap. 53.5M. do you know why yesterday the price jumped onto 24$?
        0
    • 🔴 Breaking: $IGC a cannabis stock trading at 3$ now warming up....
      0
      • Hvis market?
        0
    • Woah how can i buy or sell tjis stock
      0
      • I bought at the top and sold at the bottom lol remind me to stay away from these stocks
        0
        • Hubert Makuch @15.50 is good point to buy today?
          2
        • Gregory Aizenbergthis is short squuez, dont get fooled by that. I would buy if it closes and sustains above 25. I bought at 3.4 qnd exited at 22
          0
        • Ikode Investing it's only a gamma squeeze
          0
      • I'm thinking to buy this stock. Should I?
        2
        • not now
          0
        • 0
      • Why did it shoot up?
        0
        • US Patent and Trademark Office has granted the biotech company a patent titled "P-ethoxy nucleic acids for liposomal formulation."
          0
      • easy short squeeze to $700+
        3
        • Tell me more please
          0
        • Take no offense but... Are you kidding?
          0
      • halted?
        0
        • Another AUVI?
          0
          • RDGL 0.125 By 1/16/2021 FDA will provide a final decision to grant or deny their request for breakthrough designation.
            0
            • any news?
              0
              • bpth will skyrocket tomorrow? i hope so...
                0
                • big purchase 10 mins before closing...
                  0
                  • What is the outlook on this one?? No Hope? Any insights would be very helpful...
                    1
                    • load up for long term, july 16 2019 14.81. few years it will explode
                      0
                      • What information do you have?
                        0
                      • it's time tp explode dude
                        0
                      • it's time to explode dude
                        0
                    • Why is this popping today??? No news anywhere. Ridiculous.
                      0
                      • Sure news. Offering was canceleld. Back to the old offer at 25
                        0
                    • looking for shorts
                      1
                      • Don't believe in any report.
                        1
                        • What do you mean?
                          0
                      • Not at all what i expected.
                        0
                        • j am jump in soon....but a small portion in case
                          1
                          • Last time they released the statement about their success, the stock went mad. This recent statement confirmed more success, so a jump should be coming, but because of the overall market condition today, this is probably seeing limited jump.
                            0
                        • guess, the stock was held above 25$ for stock offering. Once thats done, it's free fall until another news triggers rally.
                          0
                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.